TrialBlood cancer journal2020

Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX.

Jonathan L Kaufman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.